US20250041300A1

Pharmaceutical combination comprising abemaciclib and a pi3k and/or a mtor …

University of Texas System

Abstract

Provided herein is a combination therapy for use in a method of treating mantle cell lymphoma in a patient in need thereof.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Luhua WANG
Priority date: December 14, 2021
Filing date: December 13, 2022
Publication date: February 06, 2025
Language: en
PDF source: https://patentimages.storage.googleapis.com/93/d2/c2/d4a0a7c94b93be/US20250041300A1.pdf
Metadata fetched: August 29, 2026 00:34